Search Results - "Subortseva, I N"

The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description by Melikyan, A L, Subortseva, I N, Gilyazitdinova, E A, Koloshejnova, T I, Egorova, E K, Pustovaya, E I, Sudarikov, A B, Abdullaev, A O, Gorgidze, L A, Chebotarev, D I

“…Primary myelofibrosis is a myeloproliferative neoplasm that occurs de novo, characterized by clonal proliferation of stem cells, abnormal expression of…”
Get full text

Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome by Melikyan, A L, Subortseva, I N, Koloshejnova, E A, Gilyazitdinova, E A, Shashkina, K S, Gorgidze, L A, Tratsevskaya, Zh V, Margolin, O V

“…Thrombosis is a serious and extremely dangerous disease that has a negative impact on the quality and longevity. Antiphospholipid syndrome (APS) is a pathology…”
Get full text

Acute ischemic stroke in the setting of essential thrombocytemia (clinical cases) by Tanashyan, M M, Kuznetsova, P I, Raskurazhev, A A, Subortseva, I N, Melikyan, A L

“…This article describes several clinical cases of acute ischemic stroke among patients suffering from essential thrombocytemia. Ambiguity of etiological factors…”
Get full text

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases by Melikyan, A L, Subortseva, I N, Gilyazitdinova, E A, Koloshejnova, T I, Pustovaya, E I, Egorova, E K, Kovrigina, A M, Sudarikov, A B, Abdullaev, A O, Lomaia, E G, Siordiya, N T, Zaritskey, A Yu, Savchenko, V G

“…A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET)…”
Get full text

Clinical and morphological features of different types of Castleman's disease by Melikyan, A L, Egorova, E K, Kovrigina, А М, Subortseva, I N, Gilyazitdinova, E A, Karagyulyan, S R, Silaev, M A, Gemdzhian, E G, Savchenko, V G

“…To study the clinical features of Castleman's disease (CD) and to elaborate therapeutic approaches in its different morphological types. The clinical and…”
Get full text

Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease by Melikyan, A L, Subortseva, I N, Sudarikov, A B, Kovrigina, A M, Gilyazitdinova, E A, Kolosheinova, T I, Abdullaev, A O, Treglazova, S A

“…The aim of the present paper was to evaluate the clinical features and risk of thrombotic events (TE) in patients with essential thrombocythemia (ET) and…”
Get full text

Experience in treating portal thromboses in patients with chronic myeloproliferative diseases by Melikyan, A L, Sukhanova, G A, Vakhrusheva, M V, Subortseva, I N, Orel, E B

“…Patients with myeloproliferative diseases (MPD) are noted to be at high risk for portal thromboses. This problem gives rise to disability if it is untimely…”
Get full text

Diagnosis of latent polycythemia vera: A clinician's opinion by Melikian, A L, Subortseva, I N, Kovrigina, A M, Kolosheynova, T I, Abdullaev, A O, Kuznetsova, P I, Sudarikov, A B, Kulikov, S M

“…to identify the clinical features of latent polycythemia vera (PV) as an independent nosological entity. The investigation enrolled 81 patients (50 with…”
Get full text

Resolution of the Expert Council on the issues of diagnosis and treatment of myeloproliferative neoplasms, existing standards and the possibility of their implementation in real clinical practice in Russia by Melikyan, A. L., Subortseva, I. N.

Get full text

Mastocytosis. Review of the literature and description of clinical cases by Melikian, A L, Subortseva, I N, Goriacheva, S R, Kolosheinova, T I, Vakhrusheva, M V, Kovrigina, A M, Sudarikov, A B, Dvirnyk, V N, Obukhova, T N

“…The term mastocytosis (MC) encompasses a group of rare diseases characterized by the tumorous proliferation of clonal mast cells and the infiltration of one or…”
Get full text

Synchronous and metachronous myeloid and lymphoid tumors by Melikian, A L, Kolosheĭnova, T I, Goriacheva, S R, Subortseva, I N, Vakhrusheva, M V, Kolosova, E N, Sudarikov, A B, Abdullaev, A O, Dvirnyk, V N, Varlamova, E Iu, Kovrigina, A M, Turkina, A G

“…To determine the clinical features of multiple primary tumors (MPT) in patients with hemoblastoses, to develop treatment policy for synchronous and…”
Get full text

Cephalalgia against the background of systemic mastocytosis: a clinical case by Kuznetsova, P. I., Tanashyan, M. M., Melikyan, A. L., Subortseva, I. N., Raskurazhev, A. A.

“…The article presents a clinical case of comorbid pathology – development of migraine against the background of systemic mastocytosis. The classification and…”
Get full text

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES by Subortseva, I. N., Melikyan, A. I.

“…Chronic myeloid malignancies that have characteristics of both the myelodysplastic and myeloproliferative disorders allocated to…”
Get full text

Differential diagnosis of thrombocytopenes by Melikyan, A. L., Pustovaya, E. I., Egorova, E. K., Kalinina, M. V., Kolosheynova, T. I., Subortseva, I. N., Gilyazitdinova, E. A., Dvirnyk, V. N.

“…The article presents a systematic diagnostic approach for thrombocytopenia, as well as the results of practical implementation of thrombocytopenia diagnostic…”
Get full text

Myeloproliferative diseases and ischemic stroke by M. M. Tanashyan, P. I. Kuznetsova, O. V. Lagoda, A. A. Shabalina, I. N. Subortseva, A. L. Melikyan

“…Myeloproliferative diseases (MPD) comprise a group of clonalpathology resulting from genetic alterations at a stem cell level.WHO (2008) divides MPD into…”
Get full text

Thrombosis in patients with myeloproliferative neoplasms. Case report by Melikyan, A L, Subortseva, I N, Gilyazitdinova, E A, Koloshejnova, T I, Shashkina, K S, Egorova, E K, Kovrigina, A M, Sudarikov, A B, Gorgidze, L A

Get full text

The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description by Melikyan, A L, Subortseva, I N, Gilyazitdinova, E A, Koloshejnova, T I, Egorova, E K, Pustovaya, E I, Sudarikov, A B, Abdullaev, A O, Gorgidze, L A, Chebotarev, D I

Get full text

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report by Kolgaeva, E I, Vasilyeva, V A, Kuzmina, L A, Drokov, M Y, Dovydenko, M V, Konova, Z V, Chebotarev, D I, Kovrigina, A M, Kamelskih, D V, Gaponova, T V, Sokolova, M A, Subortseva, I N, Melikyan, A L, Maschan, M A, Parovichnikova, E N, Savchenko, V G

Get full text

Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy by I N Subortseva, A M Kovrigina, I V Korobko, I V Poddubnaya

Get full text

Acute ischemic stroke in the setting of essential thrombocytemia (clinical cases) by Tanashyan, M M, Kuznetsova, P I, Raskurazhev, A A, Subortseva, I N, Melikyan, A L

“…This article describes several clinical cases of acute ischemic stroke among patients suffering from essential thrombocytemia. Ambiguity of etiological factors…”
Get full text